A. A health benefit plan that provides coverage for advanced metastatic cancer and associated conditions may not require, before the health benefit plan provides coverage of a prescription drug approved by the United States Food and Drug Administration, that the enrollee: 1. Fails to successfully respond to a different drug; or2. Proves a history of failure of a different drug.B. This section applies only to a drug, the use of which is: 1. Consistent with best practices for the treatment of advanced metastatic cancer or an associated condition;2. Supported by peer-reviewed, evidence-based literature; and3. Approved by the United States Food and Drug Administration.Okla. Stat. tit. 63, § 7321
Added by Laws 2023 , c. 81, s. 2, eff. 11/1/2023.